Comparison between propranolol 2% cream versus timolol 0.5% gel for the treatment of Kaposi sarcoma

Int J Dermatol. 2021 May;60(5):631-633. doi: 10.1111/ijd.15407. Epub 2021 Jan 7.

Authors

Caterina Maria Rosaria Giorgio¹, Gaetano Licata¹, Giulia Briatico¹, Graziella Babino¹, Elisabetta Fulgione¹, Alessio Gambardella¹, Roberto Alfano², Giuseppe Argenziano¹

Affiliations

¹ Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.
² Department of Anesthesiology, Surgery and Emergency, University of Campania Luigi Vanvitelli, Naples, Italy.

PMID: 33410502
DOI: 10.1111/ijd.15407

No abstract available

Publication types

Letter

MeSH terms

Adrenergic beta-Antagonists
Humans
Propranolol
Sarcoma, Kaposi* / drug therapy
Skin Neoplasms* / drug therapy
Timolol

Substances

Adrenergic beta-Antagonists
Timolol
Propranolol